Midland Bank PLC. has recently signed a Memorandum of Understanding (MoU) with Concord Diagnostics & Molecular Lab BD Ltd. and EW Villa Medica Bangladesh. This partnership aims to provide exclusive healthcare and diagnostic service benefits for the Bank’s valued customers, cardholders, employees, and their dependents.

The agreement was signed at Midland Bank PLC.’s Head Office by Mr. Imtiaz U. Ahmed, Managing Director & CEO of Midland Bank PLC., and Mr. Md. Faizur Rahman, Chairman & Managing Director of Concord Diagnostics & Molecular Lab BD Ltd., EW Villa Medica Bangladesh and Noapara Group, representing their respective organizations.

Under this agreement, Midland Bank PLC. customers and employees will receive preferential discounts and special facilities on a comprehensive range of healthcare services. These include diagnostic testing, molecular testing, radiology, preventive healthcare, wellness treatments, and other medical services provided by Concord Diagnostics & Molecular Lab BD Ltd. and EW Villa Medica Bangladesh.

Key attendees from Midland Bank PLC. included Mr. Md. Zahid Hossain, Deputy Managing Director & CRO. Representing Concord Diagnostics & Molecular Lab BD Ltd. and EW Villa Medica Bangladesh was Mr. Faiaz Ibne Rahman, Group Director of Concord Healthcare Group & Noapara Group, alongside other senior officials from both organizations.

Speaking at the ceremony, officials from both organizations expressed optimism that this partnership would enhance access to quality healthcare services, creating greater value and convenience for Midland Bank customers and employees.

This partnership aligns with Midland Bank PLC.’s ongoing commitment to deliver value-added services and life-style benefits to its customers through strategic collaborations with reputable organizations across diverse sectors.